GlassScriptPhysician profile
Stephen A Shiller
NPI 1316252315
$3,375.66
in general payments reported to CMS, 2019-2025
13 companies · $552 in 2025
The $552 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $268 · 2021: $306 · 2022: $354 · 2023: $341 · 2024: $632 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,573.56 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Clinical Trial Product |
| Radius Health, INC. | $163.44 | 2019 | |
| Spr Therapeutics, INC | $137.14 | 2024 | Sprint Pns System |
| Mdd US Operations, LLC | $130.61 | 2019 | |
| Pacira Therapeutics, INC. | $122.00 | 2019 | |
| Biodelivery Sciences International, INC. | $75.47 | 2019 | |
| Nalu Medical, INC. | $59.27 | 2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $31.35 | 2024 | Eterna |
| Medtronic, INC. | $20.41 | 2025 | Inceptiv |
| Tonix Medicines, INC. | $19.40 | 2025 | Tonmya |
| Vertos Medical, INC. | $16.85 | 2023 | Mild Device Kit |
| Mml US, INC. | $14.20 | 2025 | Reactiv8 |
| Spinal Elements, INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Shiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.